FDA Inspection 999728 — Central California Blood Center

Central California Blood Center — FEI 2970009

The FDA completed an inspection of Central California Blood Center on January 24, 2017 in Visalia, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 24, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Visalia, CA (United States)